Mixed bag of investors pile in for Algeta’s $120m CB
Algeta, a Nkr10.6bn ($174m) market capitalisation Norwegian company that develops novel cancer treatments, raised $120m from a convertible bond on Tuesday that drew a mix of hedge and long-only funds.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: